Literature DB >> 24748603

Sustained hyperoxia-induced NF-κB activation improves survival and preserves lung development in neonatal mice.

Sarah McKenna1, Katherine A Michaelis1, Fadeke Agboke2, Thanh Liu1, Kristie Han1, Guang Yang2, Phyllis A Dennery3, Clyde J Wright4.   

Abstract

Oxygen toxicity contributes to the pathogenesis of bronchopulmonary dysplasia (BPD). Neonatal mice exposed to hyperoxia develop a simplified lung structure that resembles BPD. Sustained activation of the transcription factor NF-κB and increased expression of protective target genes attenuate hyperoxia-induced mortality in adults. However, the effect of enhancing hyperoxia-induced NF-κB activity on lung injury and development in neonatal animals is unknown. We performed this study to determine whether sustained NF-κB activation, mediated through IκBβ overexpression, preserves lung development in neonatal animals exposed to hyperoxia. Newborn wild-type (WT) and IκBβ-overexpressing (AKBI) mice were exposed to hyperoxia (>95%) or room air from day of life (DOL) 0-14, after which all animals were kept in room air. Survival curves were generated through DOL 14. Lung development was assessed using radial alveolar count (RAC) and mean linear intercept (MLI) at DOL 3 and 28 and pulmonary vessel density at DOL 28. Lung tissue was collected, and NF-κB activity was assessed using Western blot for IκB degradation and NF-κB nuclear translocation. WT mice demonstrated 80% mortality through 14 days of exposure. In contrast, AKBI mice demonstrated 60% survival. Decreased RAC, increased MLI, and pulmonary vessel density caused by hyperoxia in WT mice were significantly attenuated in AKBI mice. These findings were associated with early and sustained NF-κB activation and expression of cytoprotective target genes, including vascular endothelial growth factor receptor 2. We conclude that sustained hyperoxia-induced NF-κB activation improves neonatal survival and preserves lung development. Potentiating early NF-κB activity after hyperoxic exposure may represent a therapeutic intervention to prevent BPD.
Copyright © 2014 the American Physiological Society.

Entities:  

Keywords:  IκBβ hyperoxic lung injury; NF-κB; bronchopulmonary dysplasia; lung development

Mesh:

Substances:

Year:  2014        PMID: 24748603      PMCID: PMC4060010          DOI: 10.1152/ajplung.00001.2014

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  63 in total

Review 1.  Species comparison of lung development.

Authors:  Tracey Zoetis; Mark E Hurtt
Journal:  Birth Defects Res B Dev Reprod Toxicol       Date:  2003-04

2.  IL-13 stimulates vascular endothelial cell growth factor and protects against hyperoxic acute lung injury.

Authors:  J Corne; G Chupp; C G Lee; R J Homer; Z Zhu; Q Chen; B Ma; Y Du; F Roux; J McArdle; A B Waxman; J A Elias
Journal:  J Clin Invest       Date:  2000-09       Impact factor: 14.808

3.  The IkappaB-NF-kappaB signaling module: temporal control and selective gene activation.

Authors:  Alexander Hoffmann; Andre Levchenko; Martin L Scott; David Baltimore
Journal:  Science       Date:  2002-11-08       Impact factor: 47.728

4.  Treatment of newborn rats with a VEGF receptor inhibitor causes pulmonary hypertension and abnormal lung structure.

Authors:  Timothy D Le Cras; Neil E Markham; Rubin M Tuder; Norbert F Voelkel; Steven H Abman
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2002-09       Impact factor: 5.464

5.  NF-kappaB protects lung epithelium against hyperoxia-induced nonapoptotic cell death-oncosis.

Authors:  William R Franek; Dympna M P Morrow; Hong Zhu; Ivana Vancurova; Veronika Miskolci; Kenta Darley-Usmar; H Hank Simms; Lin L Mantell
Journal:  Free Radic Biol Med       Date:  2004-11-15       Impact factor: 7.376

6.  Maturational differences in lung NF-kappaB activation and their role in tolerance to hyperoxia.

Authors:  Guang Yang; Aida Abate; Adia G George; Yi-Hao Weng; Phyllis A Dennery
Journal:  J Clin Invest       Date:  2004-09       Impact factor: 14.808

7.  The two faces of IKK and NF-kappaB inhibition: prevention of systemic inflammation but increased local injury following intestinal ischemia-reperfusion.

Authors:  Lee-Wei Chen; Laurence Egan; Zhi-Wei Li; Florian R Greten; Martin F Kagnoff; Michael Karin
Journal:  Nat Med       Date:  2003-04-07       Impact factor: 53.440

8.  Gene expression profile and histopathology of experimental bronchopulmonary dysplasia induced by prolonged oxidative stress.

Authors:  Gerry T M Wagenaar; Simone A J ter Horst; Margôt A van Gastelen; Lara M Leijser; Thais Mauad; Pieter A van der Velden; Emile de Heer; Pieter S Hiemstra; Ben J H M Poorthuis; Frans J Walther
Journal:  Free Radic Biol Med       Date:  2004-03-15       Impact factor: 7.376

9.  Hyperoxia elicits myocardial protection through a nuclear factor kappaB-dependent mechanism in the rat heart.

Authors:  Peeter Tähepõld; Jarle Vaage; Joel Starkopf; Guro Valen
Journal:  J Thorac Cardiovasc Surg       Date:  2003-03       Impact factor: 5.209

10.  Functional redundancy of the nuclear factor kappa B inhibitors I kappa B alpha and I kappa B beta.

Authors:  J D Cheng; R P Ryseck; R M Attar; D Dambach; R Bravo
Journal:  J Exp Med       Date:  1998-09-21       Impact factor: 14.307

View more
  15 in total

1.  Intrauterine growth restriction decreases NF-κB signaling in fetal pulmonary artery endothelial cells of fetal sheep.

Authors:  R Blair Dodson; Kyle N Powers; Jason Gien; Paul J Rozance; Gregory Seedorf; David Astling; Kenneth Jones; Timothy M Crombleholme; Steven H Abman; Cristina M Alvira
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-05-03       Impact factor: 5.464

2.  Lactoferrin Protects Hyperoxia-Induced Lung and Kidney Systemic Inflammation in an In Vivo Imaging Model of NF-κB/Luciferase Transgenic Mice.

Authors:  Chih-Ching Yen; Wen-Hui Chang; Min-Che Tung; Hsiao-Ling Chen; Hsu-Chung Liu; Chun-Huei Liao; Ying-Wei Lan; Kowit-Yu Chong; Shang-Hsun Yang; Chuan-Mu Chen
Journal:  Mol Imaging Biol       Date:  2020-06       Impact factor: 3.488

3.  Absence of TNF-α enhances inflammatory response in the newborn lung undergoing mechanical ventilation.

Authors:  Harald Ehrhardt; Tina Pritzke; Prajakta Oak; Melina Kossert; Luisa Biebach; Kai Förster; Markus Koschlig; Cristina M Alvira; Anne Hilgendorff
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-03-25       Impact factor: 5.464

4.  Activation of the nuclear factor-κB pathway during postnatal lung inflammation preserves alveolarization by suppressing macrophage inflammatory protein-2.

Authors:  Yanli Hou; Min Liu; Cristiana Husted; Chihhsin Chen; Kavitha Thiagarajan; Jennifer L Johns; Shailaja P Rao; Cristina M Alvira
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-07-10       Impact factor: 5.464

5.  Sex-specific differences in neonatal hyperoxic lung injury.

Authors:  Krithika Lingappan; Weiwu Jiang; Lihua Wang; Bhagavatula Moorthy
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-06-24       Impact factor: 5.464

6.  Endotoxemia Induces IκBβ/NF-κB-Dependent Endothelin-1 Expression in Hepatic Macrophages.

Authors:  Sarah McKenna; Megan Gossling; Alejandro Bugarini; Elizabeth Hill; Aimee L Anderson; Raymond C Rancourt; Natarajan Balasubramaniyan; Karim C El Kasmi; Clyde J Wright
Journal:  J Immunol       Date:  2015-09-04       Impact factor: 5.422

7.  IL-1 promotes α-epithelial Sodium Channel (α-ENaC) expression in murine lung epithelial cells: involvement of NF-κB.

Authors:  Shamimunisa B Mustafa; Tania F Hernandez; Teresa L Johnson-Pais; Pratap A Kumar; Jean A Petershack; Barbara M Henson; Steven R Seidner
Journal:  J Cell Commun Signal       Date:  2019-10-29       Impact factor: 5.782

8.  APAP-Induced IκBβ/NFκB Signaling Drives Hepatic Il6 Expression and Associated Sinusoidal Dilation.

Authors:  Laura G Sherlock; Durganili Balasubramaniyan; Lijun Zheng; Maya Grayck; William C McCarthy; Robert C De Dios; Miguel A Zarate; David J Orlicky; Robyn De Dios; Clyde J Wright
Journal:  Toxicol Sci       Date:  2022-01-24       Impact factor: 4.849

Review 9.  Pathogenesis of bronchopulmonary dysplasia: when inflammation meets organ development.

Authors:  Tayyab Shahzad; Sarah Radajewski; Cho-Ming Chao; Saverio Bellusci; Harald Ehrhardt
Journal:  Mol Cell Pediatr       Date:  2016-06-29

Review 10.  Looking ahead: where to next for animal models of bronchopulmonary dysplasia?

Authors:  Claudio Nardiello; Ivana Mižíková; Rory E Morty
Journal:  Cell Tissue Res       Date:  2016-12-05       Impact factor: 5.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.